Health · Healthcare & Policy · 2 hrs ago
China’s Glimmer Plan expands support for rare tumor patients
China’s Glimmer Plan has launched its second season to support people affected by rare tumors of bone and soft tissue.
The project will collect stories from patients, family members and doctors about giant cell tumor of tendon sheath and desmoid tumors.
These conditions are rare and can be difficult to diagnose, and patients may face unclear treatment options.
Giant cell tumor of tendon sheath is benign but can invade nearby tissue, cause pain and stiffness, and return after treatment.
Desmoid tumors do not spread to distant parts of the body, but their course is hard to predict and they can damage nearby muscles, nerves or organs.
The first season collected 32 patient stories about giant cell tumor of tendon sheath and reached more than 60,000 patients.
The new season aims to share practical experiences and improve public understanding of both conditions, with submissions open through February 27, 2027.
China’s Glimmer Plan has begun its second season, expanding its focus to patients with desmoid tumors as well as giant cell tumors of the tendon sheath.
The program is collecting stories from patients, family members and doctors about diagnosis, treatment, recovery and coping with recurrence.
The organizers say the stories will help raise public awareness and provide information and support for patients and families.
The second season began on October 26, 2026, and submissions are open until February 27, 2027.
The first season collected 32 patient stories and reached more than 60,000 patients over six months.
- Who
- The China Association for the Promotion of Health Science and Technology and the CORD Rare Disease Center are organizing the program. Patients, family members and doctors can submit stories.
- What
- The second season of the Glimmer Plan is collecting stories about two rare tumors: giant cell tumor of the tendon sheath and desmoid tumor.
- When
- It began on October 26, 2026. Submissions close on February 27, 2027.
- Where
- The program is seeking stories from across China.
- Why
- The organizers aim to raise awareness, share practical experiences and strengthen social support for patients and families.
This story does not have two clearly opposing sides.
The first season of the Glimmer Plan opened, seeking accounts from patients with giant cell tumor of the tendon sheath.
The organizers had collected 32 patient stories and reached more than 60,000 patients.
The second season of the Glimmer Plan began.
The submission period for the second season is scheduled to end.
- First season stories
- 32 collected over six months
- First season reach
- More than 60,000 patients
- Second season launch
- October 26, 2026
- Submission deadline
- February 27, 2027
- Conditions covered
- Giant cell tumor of the tendon sheath and desmoid tumor
1 source
What people are saying
Rare diseases need more people to know about them, and more people to keep doing practical work.
The second season will make this effort bigger—not only focusing on giant cell tumor of the tendon sheath, but also including desmoid tumor; not only listening to patients, but also to family members and doctors.